Cargando…

COVID-19: laboratory diagnosis for clinicians. An updating article

COVID-19 (coronavirus disease 2019) is an infectious disease caused by the new coronavirus associated with severe acute respiratory syndrome 2 (SARS-CoV-2). Coronaviridae comprises a large family, of which at least seven members are known to cause respiratory diseases in humans. Coronaviruses have t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Luisane Maria Falci, Emery, Eduardo, Andriolo, Adagmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671234/
https://www.ncbi.nlm.nih.gov/pubmed/32578747
http://dx.doi.org/10.1590/1516-3180.2020.0240.14052020
_version_ 1784832496862494720
author Vieira, Luisane Maria Falci
Emery, Eduardo
Andriolo, Adagmar
author_facet Vieira, Luisane Maria Falci
Emery, Eduardo
Andriolo, Adagmar
author_sort Vieira, Luisane Maria Falci
collection PubMed
description COVID-19 (coronavirus disease 2019) is an infectious disease caused by the new coronavirus associated with severe acute respiratory syndrome 2 (SARS-CoV-2). Coronaviridae comprises a large family, of which at least seven members are known to cause respiratory diseases in humans. Coronaviruses have the ability to infect virtually all major groups of animals and, eventually, can infect humans. SARS-CoV-2 is the third coronavirus to cross the species barrier and infect humans. This virus was identified in an outbreak of pneumonia cases in Wuhan city, Hubei province, China, in December 2019. Its entire genome is inscribed on a single strand of ribonucleic acid. Some proteins present on the surface of the virus act as facilitators for its entry into host cells, while others, apparently, are related to its pathogenesis. Coronaviruses are responsible for respiratory infections in humans and some animals. The infection is often mild to moderate in intensity, but some coronaviruses may cause serious illnesses, such as severe acute respiratory syndrome (SARS), which occurred in 2002, and the Middle East respiratory syndrome (MERS). Coronaviruses can activate an excessive and unregulated immune response, which may promote SARS development. Although the lungs are one of the target organs, the hypoxia mechanism is systemic and other organs begin to suffer both through lack of oxygen and through deregulation of inflammation control mechanisms.
format Online
Article
Text
id pubmed-9671234
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Associação Paulista de Medicina - APM
record_format MEDLINE/PubMed
spelling pubmed-96712342022-11-18 COVID-19: laboratory diagnosis for clinicians. An updating article Vieira, Luisane Maria Falci Emery, Eduardo Andriolo, Adagmar Sao Paulo Med J Updating Article COVID-19 (coronavirus disease 2019) is an infectious disease caused by the new coronavirus associated with severe acute respiratory syndrome 2 (SARS-CoV-2). Coronaviridae comprises a large family, of which at least seven members are known to cause respiratory diseases in humans. Coronaviruses have the ability to infect virtually all major groups of animals and, eventually, can infect humans. SARS-CoV-2 is the third coronavirus to cross the species barrier and infect humans. This virus was identified in an outbreak of pneumonia cases in Wuhan city, Hubei province, China, in December 2019. Its entire genome is inscribed on a single strand of ribonucleic acid. Some proteins present on the surface of the virus act as facilitators for its entry into host cells, while others, apparently, are related to its pathogenesis. Coronaviruses are responsible for respiratory infections in humans and some animals. The infection is often mild to moderate in intensity, but some coronaviruses may cause serious illnesses, such as severe acute respiratory syndrome (SARS), which occurred in 2002, and the Middle East respiratory syndrome (MERS). Coronaviruses can activate an excessive and unregulated immune response, which may promote SARS development. Although the lungs are one of the target organs, the hypoxia mechanism is systemic and other organs begin to suffer both through lack of oxygen and through deregulation of inflammation control mechanisms. Associação Paulista de Medicina - APM 2020-06-22 /pmc/articles/PMC9671234/ /pubmed/32578747 http://dx.doi.org/10.1590/1516-3180.2020.0240.14052020 Text en © 2022 by Associação Paulista de Medicina https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons license.
spellingShingle Updating Article
Vieira, Luisane Maria Falci
Emery, Eduardo
Andriolo, Adagmar
COVID-19: laboratory diagnosis for clinicians. An updating article
title COVID-19: laboratory diagnosis for clinicians. An updating article
title_full COVID-19: laboratory diagnosis for clinicians. An updating article
title_fullStr COVID-19: laboratory diagnosis for clinicians. An updating article
title_full_unstemmed COVID-19: laboratory diagnosis for clinicians. An updating article
title_short COVID-19: laboratory diagnosis for clinicians. An updating article
title_sort covid-19: laboratory diagnosis for clinicians. an updating article
topic Updating Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671234/
https://www.ncbi.nlm.nih.gov/pubmed/32578747
http://dx.doi.org/10.1590/1516-3180.2020.0240.14052020
work_keys_str_mv AT vieiraluisanemariafalci covid19laboratorydiagnosisforcliniciansanupdatingarticle
AT emeryeduardo covid19laboratorydiagnosisforcliniciansanupdatingarticle
AT andrioloadagmar covid19laboratorydiagnosisforcliniciansanupdatingarticle